Shield Therapeutics to Attend BIO-Europe® 2013

23 Oct 2013

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that Richard Jones, Chief Financial Officer, and Angela Hildreth, Group Financial Controller, will attend BIO-Europe® 2013 which takes place on Monday 4th to Wednesday 6th November in Vienna, Austria.

If you would like to arrange a meeting with a representative of Shield Therapeutics, please request a meeting via the conference partnering system. Alternatively, you can request a meeting by visiting the contact us page on Shield Therapeutics website

Back to news